iXarola® VTE
www.sanofi.com
Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and for the prevention of
recurrent deep vein thrombosis (DVT) and pulmonary embolism (PE).
iXarola® SPAF
https://www.sanofi.com/
Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation (SPAF).
Xarelto® SPAF
www.xarelto.co.za
Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation (SPAF).
Xarelto® VTE
www.xarelto.co.za
Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and for the prevention of recurrent deep vein thrombosis (DVT) and pulmonary embolism (PE).
NUBEQA® (Darolutamide)
https://health4all.bayer.co.za
NUBEQA is indicated for the treatment of adult men with
non-metastatic castration resistant prostate cancer
(nmCRPC) who are at high risk of developing metastatic disease.
Disclaimer
The MotivatoRx is a voluntary tool offered by Bayer, in order to assist in the application for reimbursement of a product. This tool assists you in completing one of the steps in the application process. This application needs to be supported by various other documentation. The manufacturer has no influence on the outcome of the application for reimbursement based on this letter. The final decision regarding reimbursement remains with the medical aid based on the merits of each application, on a case by case basis. By using the MotivatoRx, you acknowledge that the manufacturer will not be held responsible for any decision (positive or negative) taken by the medical aid, nor for the related outcome as a result of your use of this tool.